HCM
BHVN

Hollencrest Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Hollencrest Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,680
Closed -$245K – 350
2022
Q2 		$245K Buy
+1,680
New +$245K 0.03% 241
2022
Q1 		– Sell
-1,680
Closed -$232K – 402
2021
Q4 		$232K Hold
1,680
– – 0.02% 314
2021
Q3 		$233K Buy
+1,680
New +$233K 0.02% 313